| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology and Visual Sciences, 2 Molecular Biology and Pharmacology, and 3 Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri.
PURPOSE. To identify retinal proteins that are the targets of serum autoantibodies in patients with glaucoma.
METHODS. To identify retinal antigens that are recognized by the sera of patients with glaucoma, immunoreactive bands were separated, by using two-dimensional gel electrophoresis of the bovine retinal soluble fraction. A 29-kDa band was then selected for further analysis. Tryptic peptides of the 29-kDa band were analyzed using electrospray mass spectrometry to identify the protein. After protein identification, immunoreactivity against this newly identified protein was studied by Western blot analysis using sera from 65 patients with glaucoma (25 with primary open-angle glaucoma [POAG]; 40 with normal-pressure glaucoma [NPG]) and 25 age-matched healthy subjects. In addition, serum antibody titers were compared in these groups, by using a specific enzyme-linked immunosorbent assay (ELISA).
RESULTS. The 29-kDa band was identified as glutathione
S-transferase (GST). Western blot analysis revealed that
serum antibodies against GST antigen were recognized in 34 (52%) of 65
patients with glaucoma (22 of NPG and 12 of POAG) and 5 (20%) of 25
age-matched control subjects (
2 test,
P < 0.05). By ELISA, it was also found that
patients with glaucoma had higher titers of anti-GST antibody, compared
with the control group (Mann–Whitney test; NPG versus control,
P = 0.013; POAG versus control,
P = 0.0006).
CONCLUSIONS. These findings indicate that GST is one of the retinal antigens targeted by the serum antibodies detected in some patients with glaucoma.
This article has been cited by other articles:
|
|
 |
|
  Y. He, K. W. Leung, Y.-H. Zhang, S. Duan, X.-F. Zhong, R.-Z. Jiang, Z. Peng, J. Tombran-Tink, and J. Ge Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1447 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Unal, M. Guven, K. Devranoglu, A. Ozaydin, B. Batar, N. Tamcelik, E. Eroglu Gorgun, D. Ucar, and A. Sarici Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population Br. J. Ophthalmol., April 1, 2007; 91(4): 527 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tezel, X. Yang, C. Luo, Y. Peng, S. L. Sun, and D. Sun Mechanisms of Immune System Activation in Glaucoma: Oxidative Stress-Stimulated Antigen Presentation by the Retina and Optic Nerve Head Glia Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 705 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Grus, S. C. Joachim, K. Bruns, K. J. Lackner, N. Pfeiffer, and M. B. Wax Serum Autoantibodies to {alpha}-Fodrin Are Present in Glaucoma Patients from Germany and the United States. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 968 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gherghel, H. R. Griffiths, E. J. Hilton, I. A. Cunliffe, and S. L. Hosking Systemic Reduction in Glutathione Levels Occurs in Patients with Primary Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Kremmer, E Kreuzfelder, E Bachor, K Jahnke, J M Selbach, and S Seidahmadi Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies Br. J. Ophthalmol., October 1, 2004; 88(10): 1259 - 1262. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
